Topical Lidocaine (5% patch)

Treatment for Peripheral Neuropathy

Effectiveness
60%
Safety Score
85%
Clinical Trials
7
Participants
9K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
MethπŸ’€
Cigarettes🚬
Chemo☒️
Alcohol🍺
MorphineπŸ’Š
AntibioticsπŸ’‰
TylenolπŸ’Š
ExerciseπŸƒ
WaterπŸ’§
85
DangerousModerateSafe
Treatment Details
0
Topical Lidocaine (5% patch) Outcomes

for Peripheral Neuropathy

Efficacy Outcomes
Overall Effectiveness
+60%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
4 completed trials for Topical Lidocaine (5% patch) in Peripheral Neuropathy

Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy

NCT01086150COMPLETEDPHASE2, PHASE3
View Study
51 participants
INTERVENTIONAL
Albany, United States
Started: Oct 1, 2009

Symptom Management After Breast Cancer Surgery

NCT00686127COMPLETEDPHASE4
View Study
21 participants
INTERVENTIONAL
San Francisco, United States
Started: Sep 1, 2003

Topical Lidocaine: Predictors of Response in Peripheral Nerve Injury

NCT01112748COMPLETEDPHASE4
View Study
24 participants
INTERVENTIONAL
Aarhus C, Denmark
Started: Apr 1, 2010

A Mechanistic Evaluation of the Nociceptive Desensitizing Properties of Topical Capsaicin

NCT03587220COMPLETEDNA
View Study
44 participants
INTERVENTIONAL
Aalborg, Denmark
Started: Aug 1, 2018